CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Cash Flows From (Used in) Operating Activities
Income (Loss) for the period	$ (264,631)	$ (204,105)	$ (771,730)	$ 1,057,682
Items not involving cash:
Depreciation and amortization	6,115	2,964	12,234	5,970
Non-cash interest	38,247	0	75,515	0
Non-controlling interest	(1)	(3)	(4)	(3)
Shares issued for compensation	28,251	0	43,751	0
Shares issued for consulting fees	57,603	0	103,123	0
Stock-based compensation	0	0	0	70,858
Warrants issued for compensation	0	0	40,000	0
Adjustments to Reconcile Net Loss to Net Cash From (Used in) Operating Activities
Decrease/(Increase) in accounts receivable	(340,840)	(204,860)	(324,960)	83,272
Decrease/(Increase) in inventory	(31,421)	(641)	(275,856)	(177,437)
Decrease/(Increase) in other receivables and prepayments	158,970	508,715	62,617	432,745
Increase/(Decrease) in other payables and accrued liabilities	(116,466)	194,777	200,983	143,879
Increase/(Decrease) in deferred revenue	15,219	(334,650)	501,987	(1,839,826)
Net cash from (used in) operating activities	(448,954)	(37,803)	(332,340)	(222,860)
Cash Flows Used in Investing Activities
Investment in associates	0	0	0	(293,590)
Net cash used in investing activities	0	0	0	(293,590)
Cash Flows From (Used in) Financing Activities
Common shares issued for cash	0	15,000	0	100,000
Advance from related parties	342,641	0	342,641	0
(Decrease)/Increase in restricted cash	52,567	0	(64,022)	78,375
Convertible promissory note	0	0	17,000	0
Net cash from (used in) financing activities	395,208	15,000	295,619	178,375
Effect of foreign currency translation on cash and cash equivalents	261	2,221	264	2,031
Net decrease in cash and cash equivalents	(53,485)	(20,582)	(36,457)	(336,044)
Cash and cash equivalents - beginning of period	161,230	250,623	144,202	566,085
Cash and cash equivalents - end of period	$ 107,745	$ 230,041	$ 107,745	$ 230,041